Back to search

Article

Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil Syndrome

2024-12-11

Abstract excerpt

<h4>Background</h4> Flecainide and other class-Ic antiarrhythmic drugs (AADs) are widely used in Andersen-Tawil syndrome type 1 (ATS1) patients. However, class-Ic drugs might be proarrhythmic in some cases. We investigated the molecular mechanisms of class-I AADs proarrhythmia and whether they might increase the risk of death in ATS1 patients with structurally normal hearts. <h4>Methods and Results</h4> Of 53 ATS1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff91d63d-6136-5d2f-80a0-93c027716665
DOI
10.1101/2024.12.10.24318629
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Kir2.1 mutations differentially increase the risk of flecainide proarrhythmia in Andersen Tawil SyndromeDOI 10.1101/2024.12.10.24318629
Select a neighboring publication to make it the new centre.